93 7236 (Ondansetron Hydrochloride 8 mg)
Pill with imprint 93 7236 is Yellow, Round and has been identified as Ondansetron Hydrochloride 8 mg. It is supplied by Teva Pharmaceuticals USA.
Ondansetron is used in the treatment of nausea/vomiting; nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative; nausea/vomiting, radiation induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7236



Ondansetron Hydrochloride
- Imprint
- 93 7236
- Strength
- 8 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- 5HT3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s), lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, polyethylene glycol 6000, polyethylene glycol 400, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00093-7236 | Teva Pharmaceuticals USA, Inc. |
35356-0445 | Lake Erie Medical and Surgical Supply (repackager) |
Related Images for "93 7236"
More about ondansetron
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 394 Reviews
- Drug class: 5HT3 receptor antagonists
- FDA Alerts (5)
Consumer resources
- Ondansetron
- Ondansetron injection
- Ondansetron Oral, Injection, Intravenous (Advanced Reading)
- Ondansetron Oral, Oromucosal (Advanced Reading)
- Ondansetron Orally Disintegrating Tablets
- ... +3 more
Other brands: Zofran, Zofran ODT, Zuplenz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.